Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity
2007 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Influence of Antibiotic Therapy on Mortality of Critical Surgical Illness Caused or Complicated by Infection
2005
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem
2013
Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004
2005
Emerging antibiotic resistance in urinary tract pathogens
2003
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
2006
Early Lactate-Guided Therapy in Intensive Care Unit Patients
2010
Lactobacillus rhamnosus bacteremia: an emerging clinical entity
2012
A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment
2006 Standout
Priorities for antibiotic resistance surveillance in Europe
2006
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
2017 Standout
Community-associated meticillin-resistant Staphylococcus aureus
2010
Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites
2015
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Community-associated meticillin-resistant Staphylococcus aureus: epidemiology, microbiology and clinical impact in East Yorkshire, UK
2009
Epidemiological typing of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital
1997
Severe Sepsis and Septic Shock
2013 Standout
Treatment of Community-Acquired Acute Uncomplicated Urinary Tract Infection with Sparfloxacin versus Ofloxacin
1998
Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study
2015
Effects of Linezolid on Suppressing In Vivo Production of Staphylococcal Toxins and Improving Survival Outcomes in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia
2013
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Risk factors and evolution of Ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian University Hospital
2008
Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom
2009
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION
1997 Standout
Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum -lactamases in a university hospital
1998
Bacterial Coinfection in Influenza
2013
Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997–2002)
2005
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
2014
Swab Sample Transfer for Point-Of-Care Diagnostics: Characterization of Swab Types and Manual Agitation Methods
2014
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Probiotic Prophylaxis of Ventilator-associated Pneumonia
2010
Sepsis and septic shock
2018 Standout
In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii
2005
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
2004
Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care
2014 Standout
Résultats de l’enquête de prévalence des infections nosocomiales au CHNU de Fann (Dakar, Sénégal)
2008
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
2017 Standout
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment
2012
Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
2010
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Optimal use of antibiotic resistance surveillance systems
2004
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
2010
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
2014
Amoxicillin-Clavulanate vs Ciprofloxacin for the Treatment of Uncomplicated Cystitis in Women
2005
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
2020 Standout
Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America
2002
Antibiotic resistance surveillance: action for international studies
2002
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
Cunning and community-acquired pneumonia
2009
Uncomplicated Urinary Tract Infection
2012 Standout
Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: Results of a randomized controlled trial
2006
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
2006
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
The current management strategies for community-acquired urinary tract infection
2003
Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002
2004
Molecular characterization and susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from hospitals and the community in Vladivostok, Russia
2009
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Efflux-mediated antimicrobial resistance
2005
Quantifying the Impact of Extranasal Testing of Body Sites for Methicillin-ResistantStaphylococcus aureusColonization at the Time of Hospital or Intensive Care Unit Admission
2012
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
2004 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Guideline for Prevention of Nosocomial Pneumonia
1994
Durée de l’antibiothérapie lors du traitement des pneumopathies acquises sous ventilation mécanique : comparaison entre sept jours et dix jours. Étude pilote
2008
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
2011
Ventilator-associated Pneumonia
2002 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review
2017
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
2015
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States
2002
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals
1996
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Probiotics for preventing ventilator-associated pneumonia
2014
Treatments for symptomatic urinary tract infections during pregnancy
2011
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Lactobacillus Sepsis and Probiotic Therapy in Newborns: Two New Cases and Literature Review
2015
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections
2001
Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility
2002
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network
2002 Standout
Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update
2014
Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease
2006
Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000
2002
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Lactobacillus Sepsis Associated With Probiotic Therapy
2005
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli
1998 StandoutScience
Origins and Evolution of Antibiotic Resistance
2010 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
2020 Standout
Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic‐associated diarrhoea in children
2008
Global antibiotic resistance in Streptococcus pneumoniae
2002
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
2002
Antibiotic Resistance Genes as Emerging Contaminants: Studies in Northern Colorado
2006 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of R.G. Masterton being referenced
A European care bundle for prevention of ventilator-associated pneumonia
2010
The place of guidelines in hospital-acquired pneumonia
2007
Appropriate antimicrobial treatment in nosocomial infections—the clinical challenges
2003
Determining the value of antimicrobial surveillance programs
2001
Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme
2004
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community
2008
The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe
2004
Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study
2011
Nasal Swab Screening for Methicillin-Resistant Staphylococcus aureus—How Well Does It Perform? A Cross-Sectional Study
2012
High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women
1995
A European care bundle for management of ventilator-associated pneumonia
2010
Antibiotic De-Escalation
2010
Results of two worldwide surveys into physician awareness and perceptions of extended-spectrum β-lactamases
2004
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
2008
Cross infection in an intensive care unit by Klebsiella pneumoniae from ventilator condensate
1993
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
2012
Lactobacillus rhamnosus infection in a child following bone marrow transplant
1996
Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis
2001
Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development
2007
Surveillance studies: how can they help the management of infection?
2000
Single‐dose amoxycillin in the treatment of bacteriuria in pregnancy and the puerperium‐a controlled clinical trial
1985